"AMRA-derived body composition data enables us at Human Longevity Inc to integrate quantitative imaging results with genomic and clinical biomarkers to give our clients and their physicians a comprehensive evaluation of their risk for diabetes, cardiovascular disease and metabolic syndrome."

"By employing AMRA’s automated analysis, we are now able to efficiently provide more actionable data to our pharmaceutical partners."

"Working with AMRA ensures high-quality, accurate data acquisition in our clinical studies that will be used to transform patient care for the future."

"I am very impressed with the body composition analysis that AMRA offers. The system works well and we get valuable data in a fast way. I am very pleased with the extra opportunities this will provide us to further improve our scientific research. The people are great to work with and there is fast, good service"

"The partnership with AMRA makes it possible to get scan results produced at Scannexus and Maastricht UMC+ to researchers much faster. Researchers now have one point of contact for support with their research."